Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
Top Cited Papers
- 20 September 2015
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 33 (27), 3065-3073
- https://doi.org/10.1200/jco.2014.60.6376
Abstract
Advances in the treatment of childhood cancers have resulted in part from the development of national and international collaborative initiatives that have defined biologic determinants and generated risk-adapted therapies that maximize cure while minimizing acute and long-term effects. Currently, more than 80% of children with cancer who are treated with modern multidisciplinary treatments in developed countries are cured; however, of the approximately 160,000 children and adolescents who are diagnosed with cancer every year worldwide, 80% live in low- and middle-income countries (LMICs), where access to quality care is limited and chances of cure are low. In addition, the disease burden is not fully known because of the lack of population-based cancer registries in low-resource countries. Regional and ethnic variations in the incidence of the different childhood cancers suggest unique interactions between genetic and environmental factors that could provide opportunities for etiologic research. Regional collaborative initiatives have been developed in Central and South America and the Caribbean, Africa, the Middle East, Asia, and Oceania. These initiatives integrate regional capacity building, education of health care providers, implementation of intensity-graduated treatments, and establishment of research programs that are adjusted to local capacity and local needs. Together, the existing consortia and regional networks operating in LMICs have the potential to reach out to almost 60% of all children with cancer worldwide. In summary, childhood cancer burden has been shifted toward LMICs and, for that reason, global initiatives directed at pediatric cancer care and control are needed. Regional networks aiming to build capacity while incorporating research on epidemiology, health services, and outcomes should be supported.Keywords
This publication has 57 references indexed in Scilit:
- Trans-population Analysis of Genetic Mechanisms of Ethnic Disparities in Neuroblastoma SurvivalJNCI Journal of the National Cancer Institute, 2012
- ARID5B Genetic Polymorphisms Contribute to Racial Disparities in the Incidence and Treatment Outcome of Childhood Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2012
- Disparities in cancer outcomes: Lessons learned from children with cancerPediatric Blood & Cancer, 2011
- Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaNature Genetics, 2011
- Effects on patients of their healthcare practitioner's or institution's participation in clinical trials: a systematic reviewTrials, 2011
- Expansion of cancer care and control in countries of low and middle income: a call to actionThe Lancet, 2010
- Childhood cancer in relation to parental race and ethnicityCancer, 2010
- Pediatric oncology in India: Past, present and futureIndian Journal of Medical and Paediatric Oncology, 2009
- Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive studyThe Lancet Oncology, 2008
- Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year peroidEuropean Journal of Cancer, 2005